INDICATION

Aptensio XR® (methylphenidate HCl extended-release) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

For US Healthcare Professionals

IMPORTANT SAFETY INFORMATION

WARNING: ABUSE AND DEPENDENCE

CNS stimulants, including Aptensio XR, other methylphenidate-containing products, and amphetamines, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.

.

SAVINGS OFFER

The Aptensio XR® Patient Access Support Program can help your patients afford treatment

.
Aptesio XR Copay Saving Card
  • Copay support: Eligible patients pay as little as a $30 copay for their Aptensio XR® (methylphenidate HCl extended-release) prescriptions with a monthly maximum benefit of $150
  • Insurance support: A program is available to assist if prior authorizations are required by insurance plans

If you would like assistance in locating Aptensio XR in your area, we can help. Call customer service at 888-827-0616.

.

IMPORTANT SAFETY INFORMATION

WARNING: ABUSE AND DEPENDENCE

CNS stimulants, including Aptensio XR, other methylphenidate-containing products, and amphetamines, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.